debate: hodgkin lymphoma patient who relapses after autologous sct - serial novel agents
Published 8 years ago • 1.3K plays • Length 12:11Download video MP4
Download video MP3
Similar videos
-
13:03
debate: hodgkin lymphoma patient who relapses after autologous sct - allogeneic sct
-
13:16
debate: hodgkin lymphoma patient who remains pet at the end of chemotherapy - sct-based therapy
-
15:00
debate: hodgkin lymphoma patient who remains pet at the end of chemotherapy - radiation therapy
-
10:51
debate: relapsed 60 y/o follicular lymphoma patient after upfront r-chop - sct
-
14:44
debate: follicular lymphoma patient with early progression - novel agents
-
15:04
debate: best second line therapy for relapsed hodgkin lymphoma - brentuximab alone/ chemo
-
14:18
debate: young patient with recurrent follicular lymphoma and short remission? - novel agents/chemo
-
14:29
debate: what is the best approach for relapsed t cell lymphoma? - allosct
-
16:18
my stem cell transplant experience for hodgkin's lymphoma
-
19:59
the advocate trial: a conversation with dr. peter a. merkel
-
4:57
rabbi, dad, cancer survivor | ben's story
-
10:46
debate: value to using brentuximab vedotin consolidation early after auto-sct in hodgkin's? - yes
-
15:15
debate: best second-line approach to induce lymphoma remission prior to sct? - brentuximab
-
11:11
debate: should younger patients with mantle cell lymphoma receive upfront autologous sct? - yes
-
23:41
recurrent follicular lymphoma: novel approaches vs stem cell transplant
-
15:05
debate: a case of relapsed peripheral t-cell lymphoma - stem cell transplant
-
8:40
debate: value to using brentuximab vedotin consolidation early after auto-sct in hodgkin's? - no
-
13:31
debate: a case of advanced stage mantle cell lymphoma - chemoimmunotherapy with autosct
-
14:34
debate: best pre-transplant second line therapy for relapsed hodgkin lymphoma - chemo alone
-
11:21
debate: brentuximab vedotin as upfront therapy for advanced hodgkin lymphoma? - yes
-
18:13
how can we make hodgkin's disease therapy less toxic and more effective?
-
9:27
debate: relapsed mantle cell lymphoma - cell based therapies with allo